Similar dermatitis incidence and severity, but lower rate of severe pruritis and skin pain.

Diarrhea, colitis are common reasons for ED visits.

A novel treatment option for impetigo in patients aged 2 months and older.

Update of 2016 ICER report includes new targeted agents.

Findings warrant phase 3 evaluation.

Managing the post-polio transition featured among issues addressed by world leaders at the G7 summit.

Absolute risk remains low.

Part 2 of guideline, which updates 2012 recommendations.

New drug may eventually be first systemic therapy for advanced cSCC.

Iterative Delphi process addresses lack of consensus in trial design.

Improvement occurs regardless of prior anti-TNF therapy.

Consensus recommendations are an update on 2013 guidelines and reflect new treatment options.

Study shows preliminary evidence for efficacy of 0.5% colchicine cream, a low-cost drug.

Retrospective cohort study of more than 22,000 individuals.